Evidence map›Paper›PMID 38609695›Full record

ArticleJournal of racial and ethnic health disparities2025

Police Harassment and Psychiatric, Sexual, and Substance Use Risk Among Black Sexual Minority Men and Black Transgender Women in the HIV Prevention Trials 061 Cohort.

Jonathan Feelemyer, Dustin T Duncan, Naomi Akhidenor, Medha Mazumdar, Natalia M Irvine, Joy D Scheidell, Russell A Brewer, Rodman E Turpin, Christopher Hucks-Ortiz, Typhanye V Dyer and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of racial and ethnic health disparities, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Jonathan FeelemyerDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, USA. jf3880@nyu.edu.ORCID 0000-0001-6617-4992
Dustin T DuncanDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Naomi AkhidenorDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
Medha MazumdarDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
Natalia M IrvineDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
Joy D ScheidellDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
Russell A BrewerDepartment of Medicine, University of Chicago, Chicago, IL, USA.
Rodman E TurpinDepartment of Epidemiology and Biostatistics, University of Maryland School of Public Health, College Park, MD, USA.
Christopher Hucks-OrtizBlack AIDS Institute, Los Angeles, CA, USA.
Typhanye V DyerDepartment of Epidemiology and Biostatistics, University of Maryland School of Public Health, College Park, MD, USA.
Charles M ClelandDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
Kenneth H MayerFenway Institute, Fenway Health and Department of Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA.
Maria R KhanDepartment of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
New York University · USUniversity of Maryland, College Park · USBeth Israel Deaconess Medical Center · USBlack AIDS Institute · USColumbia University · USUniversity of Chicago · US

Funding

LOC: HIV Prevention Trials NetworkUM1AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI Sinead Delany-Moretlwe, RAPHAEL J LANDOVITZ · 2011 to 2026
$779.5M
SDMC: HPTN 084 Pregnancy SupplementUM1AI068617 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Elizabeth Renata Brown, Deborah J Donnell · 2011 to 2026
$204.9M
LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)UM1AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SUSAN H ESHLEMAN, Mark A Marzinke · 2011 to 2026
$100.2M
The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ARTHUR Y KIM · 2004 to 2026
$94.4M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
HIV Prevention trials Network (HPTN) Coordinating and Operations CenterU01AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI VERMUND, STEN H. · 2006 to 2010
$72.7M
Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
San Francisco Vaccine and Prevention UnitUM1AI069496 · NIAID · PUBLIC HEALTH FOUNDATION ENTERPRISES · PI Susan Buchbinder, Diane V Havlir · 2012 to 2026
$30.5M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025008 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$29.0M
Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials NetworkU01AI068617 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DONNELL, DEBORAH J · 2006 to 2010
$28.8M
HIV Prevention Trials Network: Network LaboratoryU01AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI ESHLEMAN, SUSAN H · 2006 to 2010
$16.5M
Centers for Innovative Research to Control AIDSU01AI069466 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI EL-SADR, WAFAA M. · 2007 to 2011
$14.0M
National Institute of Allergy and Infectious Diseases 3U01 AI069466-03S1National Institute of Allergy and Infectious Diseases 3U01 AI069496-03S1National Institute of Allergy and Infectious Diseases 3U01 AI069496-03S2National Institute of Allergy and Infectious Diseases 5U01 AI069466National Institute of Allergy and Infectious Diseases P30DA027828National Institute of Allergy and Infectious Diseases U01AI069424National Institute of Allergy and Infectious Diseases UM1AI068619NCCDPHP CDC HHS U48 DP005008NCCDPHP CDC HHS U48 DP006382NCRR NIH HHS UL1 RR025008NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI060354NIAID NIH HHS P30 AI087714NIAID NIH HHS U01 AI068613NIAID NIH HHS U01 AI068617NIAID NIH HHS U01 AI068619NIAID NIH HHS U01 AI069418NIAID NIH HHS U01 AI069424NIAID NIH HHS U01 AI069466NIAID NIH HHS U01 AI069480NIAID NIH HHS U01 AI069496NIAID NIH HHS UM1 AI068613NIAID NIH HHS UM1 AI068617NIAID NIH HHS UM1 AI068619NIAID NIH HHS UM1 AI069466NIAID NIH HHS UM1 AI069480NIAID NIH HHS UM1 AI069496NIDA NIH HHS P30 DA011041NIDA NIH HHS P30 DA027828NIDA NIH HHS R01 DA028766NIDA NIH HHS R01 DA044037NIDA NIH HHS R01DA044037
6 · The paper itself

Abstract

backgroundBlack sexual minority men and Black transgender women (BSMM/BTW) experience disproportionate levels of HIV/STI-related risk factors as well as police harassment (PH). PH is linked to psychiatric risk and could play a role in substance use, sexual risk behavior, and HIV/STI risk.

methodsWe used data from the HIV Prevention Trials Network 061(HPTN 061) study to examine associations between PH and HIV/STI-related outcomes. Using PH exposure measured at baseline and 6-month study visits, we examined an ordinal exposure (PH reported at both visits, PH reported at either visit, versus PH reported at neither baseline nor 6 months) and a binary exposure of persistent PH reported at both visits (yes versus no). We estimate risk ratios (RR) for associations between PH and depression, use of alcohol and methamphetamine, multiple partnerships, condomless sex, and syphilis.

resultsPersistent PH (binary) was associated with a 20% or greater increase in the risk of depression (RR, 1.26 (1.07, 1.47)) and multiple partnerships (RR, 1.20 (1.05, 1.39)). There was evidence that ordinal PH was associated with elevated risk of alcohol use (RR, 1.17 (1.00, 1.36)); the point estimate for the association between persistent PH and alcohol use was similar but the imprecision was greater (RR, 1.16 (0.95, 1.42)).

conclusionPH may influence not only mental health but also behavioral risks that contribute to HIV/STI among BSMM/BTW, highlighting the potential wide-ranging and downstream effects of PH on health. Further research is required to confirm associations and elucidate pathways through which PH may influence HIV/STI among BSMM/BTW.

Indexed as

Black or African AmericanHIV InfectionsPoliceSexual and Gender MinoritiesSubstance-Related DisordersTransgender PersonsAdultFemaleHumansMaleMiddle AgedRisk FactorsRisk-TakingSexual BehaviorYoung AdultBlack sexual minority malesBlack transgender womenPolice harassmentSexual risk behaviorSubstance use

Identifiers

PMID38609695
PMCPMC11470103
OpenAlexW4394770153

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.